Market foothold Isogen Life Science has over 30 years in bioresearch tools and serves biotech companies and leading research institutes, presenting a stable customer base and potential repeat business for instruments, reagents, and consumables.

Regional reach Headquartered in the Netherlands with sales operations across the Benelux and parts of Europe (Spain, Portugal, UK) indicating opportunity to expand cross-border sales, channel partnerships, and localized service offerings.

Service capability In-house IQ/OQ/PQ service capability suggests potential after-sales differentiator for customers needing validated equipment, enabling upsell of calibration, maintenance contracts, and training services.

Asset transition Recent asset sale in 2022 to Mikrobiomik Healthcare implies potential consulting or replenishment needs for customers managing microbial detection equipment, with upsell potential around related cell biology and microbiology tools.

Growth signals Revenue is under $1M with a lean team, indicating high upside through targeted outreach to similar-sized labs and institutes, leveraging cost-effective digital channels and partnerships to scale sales of specialized reagents and instruments.